Diabetic Peripheral Neuropathy (DPN) Completed Phase 3 Trials for Capsaicin (DB06774)

Also known as: Diabetic Neuropathy Peripheral / Peripheral Diabetic Neuropathy / Diabetic Peripheral Neuropathy / Peripheral neuropathy due to diabetes mellitus (disorder) / Diabetic neuropathy / Diabetic Neuropathies / Diabetes + neuropathy (& [amyotrophy]) / Diabetic neuropathy (disorder) [Ambiguous] / Diabetic neuropathy &/or diabetic polyneuropathy / Diabetes mellitus with neurological manifestation: (& [amyotrophy] or [neuropathy] or [polyneuropathy]) / Diabetes mellitus NOS with neurological manifestation (disorder) / Neuropathy due to diabetes mellitus (disorder)

IndicationStatusPhase
DBCOND0049986 (Diabetic Peripheral Neuropathy (DPN))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT031134480.075% Capsaicin Lotion for the Treatment of Painful Diabetic NeuropathyTreatment
NCT01533428A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)Treatment